Bond Crédit Agricole SA 2.811% ( US225313AN57 ) in USD
Issuer | Crédit Agricole SA | ||
Market price | ![]() |
||
Country | ![]() |
||
ISIN code |
![]() |
||
Interest rate | 2.811% per year ( payment 2 times a year) | ||
Maturity | 10/01/2041 | ||
|
|||
Minimal amount | 250 000 USD | ||
Total amount | 1 500 000 000 USD | ||
Cusip | 225313AN5 | ||
Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||
Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||
Next Coupon | 11/01/2026 ( In 119 days ) | ||
Detailed description |
Crédit Agricole is a French multinational cooperative banking group with a global presence, offering a wide range of financial services including retail banking, investment banking, and asset management. For investors seeking long-term debt instruments, a specific obligation issued by Crédit Agricole, one of France's largest cooperative financial institutions, presents a notable opportunity. Identified by ISIN US225313AN57 and CUSIP 225313AN5, this bond carries a total issuance size of $1.5 billion USD, underscoring the scale of its offering in the market. Crédit Agricole, as the issuer, is a leading French universal bank with a strong domestic presence and significant international operations, active across retail banking, corporate and investment banking, asset management, and insurance. The bond, denominated in USD despite its French origin, offers an annual interest rate of 2.811%, distributed semi-annually, reflecting a payment frequency of two times per year. With a distant maturity date of October 1, 2041, it represents a long-duration asset, potentially appealing to investors with a long-term horizon. The bond is currently trading on the secondary market at 67.6% of its par value, indicating it is available at a significant discount, which could translate into a higher yield to maturity for buyers at this price. This instrument targets sophisticated investors, evidenced by its minimum purchase size set at $250,000. Its credit quality is affirmed by leading rating agencies, holding an investment-grade rating of BBB+ from Standard & Poor's (S&P) and Baa1 from Moody's, reflecting the issuer's robust financial health and capacity to meet its debt obligations. |